Alnylam Pharmaceuticals (ALNY.MX) Q1 2019 Earnings

Feb 7Confirmed
Q2 2018
Q3 2018
Q4 2018
Q1 2019
-48.26
-41.13
-34
-26.87

Details

Expected EPS
-43.93828
Actual EPS
-39.926524
Surprise EPS
4.01
Surprise Percent
+9.13%

Description

⁨Alnylam Pharmaceuticals⁩ (⁦ALNY.MX⁩) has reported earnings of ⁦-39.926524⁩ per share for ⁦Q1 2019⁩.

0 Comments

Share your thoughts